NASDAQ:SYBX
Synlogic Inc Stock News
$1.80
+0.0100 (+0.559%)
At Close: May 13, 2024
Why Are Synlogic Shares Moving Higher Premarket Monday?
08:31am, Monday, 20'th Sep 2021
Synlogic Inc (NASDAQ: SYBX) has announced data from clinical studies evaluating SYNB1618 and SYNB1934 for phenylketonuria (PKU). PKU is a rare genetic disease that manifests at birth and is charact
SYBX Stock: Why It Increased Today
08:20am, Monday, 20'th Sep 2021
The stock price of Synlogic Inc (NASDAQ: SYBX) increased by over 7% pre-market today. This is why it happened.
Synlogic Announces Positive Phase 2 Data Demonstrating Reduction in Plasma Phenylalanine Levels in Patients with Phenylketonuria
06:30am, Monday, 20'th Sep 2021
CAMBRIDGE, Mass., Sept. 20, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced positi
Synlogic Presents Data on SYNB8802 for Enteric Hyperoxaluria at American Urological Association (AUA) Annual Meeting
10:29am, Friday, 10'th Sep 2021
CAMBRIDGE, Mass., Sept. 10, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that i
Synlogic Presents at Global PKU Patient Meeting
10:27am, Friday, 10'th Sep 2021
CAMBRIDGE, Mass., Sept. 10, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today presented on the
Synlogic, Inc. (SYBX) CEO Aoife Brennan on Q2 2021 Results - Earnings Call Transcript
11:52am, Thursday, 12'th Aug 2021
Synlogic, Inc. (SYBX) CEO Aoife Brennan on Q2 2021 Results - Earnings Call Transcript
Synlogic, Inc. (SYBX) Reports Q2 Loss, Tops Revenue Estimates
10:06am, Thursday, 12'th Aug 2021
Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 3.45% and 23.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Synlogic Reports Second Quarter Financial Results and Provides Business Update
06:30am, Thursday, 12'th Aug 2021
CAMBRIDGE, Mass., Aug. 12, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today reported financial
Synlogic Announces Second Quarter 2021 Conference Call & Participation in Upcoming Banking Conference
09:00am, Thursday, 05'th Aug 2021
CAMBRIDGE, Mass., Aug. 5, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the Comp
CAMBRIDGE, Mass., July 22, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today the publ
Synlogic's (SYBX) Begins Phase I Study for PKU Treatment
12:26pm, Friday, 16'th Jul 2021
Synlogic (SYBX) initiates phase I study of SYNB1934, a synthetic biotic candidate to treat PKU. The drug is an evolved strain of SYNB1618, another PKU candidate currently undergoing phase II study.
Synlogic Announces Initiation of Phase 1 Study of SYNB1934, a Next-Generation Strain for the Treatment of Phenylketonuria (PKU)
06:30am, Thursday, 15'th Jul 2021
CAMBRIDGE, Mass., July 15, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that i
Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease
07:30am, Thursday, 17'th Jun 2021
CAMBRIDGE, Mass., June 17, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today that it
CAMBRIDGE, Mass., June 15, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today presented on the d
Synlogic to Present at Upcoming Virtual Banking and Industry Conference
08:30am, Tuesday, 25'th May 2021
CAMBRIDGE, Mass., May 25, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that Aoi
